BioSapien Nominated for 2026 Prix Galien Best Startup Award
San Diego, California, August 14, 2026 BioSapien Inc., a biotechnology company developing localized drug-delivery technologies for cancer treatment, has...
lung cancer
Advertisement
Freenome Gains FDA Breakthrough Device Designation
Brisbane, California, August 12, 2026 Freenome, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough...
Taiho Oncology Advances Zipalertinib in Phase 3 Trial
Princeton, New Jersey, Tokyo, Japan & Cambridge, Massachusetts, August 12, 2026 Taiho Oncology, Taiho Pharmaceutical, and Cullinan Therapeutics announced...
bioAffinity Technologies Reports CyPath Lung Growth
SAN ANTONIO, Texas, August 7, 2026 bioAffinity Technologies reported second quarter 2026 financial results highlighted by continued commercial momentum...
Invenio Imaging Completes Enrollment in AI Lung Cancer Study
San Jose, California, August 3, 2026 Invenio Imaging announced the completion of patient enrollment in the ON-SITE pivotal study,...
Advertisements
Akeso Doses First Patient in HER3 ADC Lung Cancer Trial
Hong Kong, July 27, 2026 Akeso, Inc. has announced that the first patient has been dosed in the Phase...
bioAffinity Technologies Publishes Clinical Framework for CyPath Lung
SAN ANTONIO, July 27, 2026 bioAffinity Technologies, Inc. announced the publication of a comprehensive clinical review and white paper...
Verastem Oncology Doses First Patient in Phase 2 VS-7375 NSCLC Trial
BOSTON, July 22, 2026 Verastem Oncology has announced that the first patient has been dosed in the TARGET-D 202...
Xodus Medical Study Validates Hot Pink Pad Performance
PITTSBURGH, Pa., July 23, 2026 Xodus Medical has announced encouraging results from a new observational clinical study demonstrating that...
GSK Wins FDA Approval for Jideytro in ROS1+ Lung Cancer
LONDON, United Kingdom, July 23, 2026 GSK plc has announced that the U.S. Food and Drug Administration (FDA) has...
Advertisement
